Birmingham, AL, United States of America

Reshmi Mukerji


Average Co-Inventor Count = 6.0

ph-index = 1

Forward Citations = 1(Granted Patents)


Company Filing History:


Years Active: 2023

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Reshmi Mukerji: Innovator in Pneumococcal Vaccine Development

Introduction

Reshmi Mukerji is a prominent inventor based in Birmingham, AL (US). She has made significant contributions to the field of immunology, particularly in the development of vaccines. Her innovative work focuses on enhancing the effectiveness of pneumococcal vaccines.

Latest Patents

Reshmi Mukerji holds a patent for a pneumococcal vaccine that combines selected alpha helical domains and proline-rich domains of pneumococcal surface protein A. The patent describes compositions and methods related to novel recombinant protein immunogens. These immunogens comprise specific portions of alpha helical domains (aHD) and proline-rich regions (PRD) of pneumococcal surface protein A (PspA). The aHD and PRD proteins are linked to create aHD-PRD constructs, which are designed to maximize cross-reactivity and provide protection against a broad spectrum of pneumococcal serotypes. The immunogenic compositions, including vaccines, may also include a non-linked aHD portion. Additionally, the patent covers recombinant nucleic acid molecules that encode aHD-PRD constructs, vectors, and recombinant host cells containing such molecules. The expression products are intended to elicit an immune or protective response against pneumococcal disease in suitable hosts.

Career Highlights

Throughout her career, Reshmi Mukerji has worked with esteemed organizations such as the UAB Research Foundation and the University of Tokyo. Her research has significantly advanced the understanding of pneumococcal diseases and the development of effective vaccines.

Collaborations

Reshmi has collaborated with notable colleagues, including David E. Briles and Hiroshi Kiyono. These partnerships have contributed to her innovative research and the successful development of her patented vaccine.

Conclusion

Reshmi Mukerji is a trailblazer in the field of vaccine development, particularly for pneumococcal diseases. Her innovative work and collaborations have the potential to make a significant impact on public health.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…